Triple #21367
high ConfidenceKnowledge triple
next-generation_sequencing
Molecular detection technology
Level 18
→
is_recommended_to_identify
Diagnostic relationship
→
MAPK/ERK_pathway_mutations_for_targeted_therapy
Molecular diagnostic markers
Level 5
Original triple： Next-generation sequencing#is recommended to identify#MAPK/ERK pathway mutations for targeted therapy
Evidence and Confidence
| Confidence: | high |
| Evidence Strength: | Clinical + Molecular Testing |
| Condition Dependency: | Technical conditions: genetic_testing |
| Fact or Inference: | Fact |
Clinical Relevance
| Clinical Relevance: | Treatment guidance |
Other Info
| PMID: | 37167084 ↗ |
| Knowledge Particle: | KP11 |
| Value Leadboard: | - |
| Disease: | Rosai-Dorfman disease |
| Pathway: | MAPK/ERK |